Coronavirus Disease-2019 in the Immunocompromised Host

Christopher D. Bertini,Fareed Khawaja,Ajay Sheshadri

DOI: https://doi.org/10.1016/j.idc.2023.12.007

IF: 5.905

2024-01-27

Infectious Disease Clinics of North America

Abstract:• Immunocompromise refers to a host's inability to combat infections from a variety of partial or total immune defects and can occur in the setting of diseases such as hematologic malignancies, immunosuppression use, primary immunodeficiency syndromes, and human immunodeficiency virus infection. • Hospitalization risk, intensive care unit admission, and mortality are substantially higher after severe acute respiratory syndrome coronavirus 2 pneumonia in immunocompromised hosts. • Immunocompromised Immunocompromise refers to a host's inability to combat infections from a variety of partial or total immune defects and can occur in the setting of diseases such as hematologic malignancies, immunosuppression use, primary immunodeficiency syndromes, and human immunodeficiency virus infection. Hospitalization risk, intensive care unit admission, and mortality are substantially higher after severe acute respiratory syndrome coronavirus 2 pneumonia in immunocompromised hosts. Immunocompromised

immunology,infectious diseases